Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Genome Research|September 21, 2018
Targeted genome fragmentation with CRISPR/Cas9 enables fast and efficient enrichment of small genomic regions and ultra-accurate sequencing with low DNA input (CRISPR-DS)Daniela Nachmanson, Shenyi Lian, Elizabeth K Schmidt, et al.
The American Journal of Surgical Pathology|February 20, 2022
Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric AdenomaPedram Argani, Satish K Tickoo, Andres Matoso, et al.
International Journal of Radiation Oncology, Biology, Physics|December 23, 2008
Radiosensitization by inhibiting STAT1 in renal cell carcinomaZhouguang Hui, Maria Tretiakova, Zhongfa Zhang, et al.
The American Journal of Surgical Pathology|June 26, 2023
Renal Neoplasia Occurring in Patients With PTEN Hamartoma Tumor Syndrome : Clinicopathologic Study of 12 Renal Cell Carcinomas From 9 Patients and Association With Intrarenal "Lipomas"Diana Kozman, Chia-Sui Kao, Jane K Nguyen, et al.
Cancer Research|April 3, 2008
Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic targetKenjiro Sawada, Anirban K Mitra, A Reza Radjabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane modelUrszula Dougherty, Amikar Sehdev, Sonia Cerda, et al.
Nutrition and Cancer|April 30, 2008
Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding proteinSharad Khare, Reba Mustafi, Sonia Cerda, et al.
Cancer Research|January 20, 2007
Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesisAlessandro Fichera, Nathaniel Little, Sujatha Jagadeeswaran, et al.
Molecular Cancer Therapeutics|December 12, 2013
Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancerCleo E Rolle, Rajani Kanteti, Mosmi Surati, et al.
Breast Cancer Research and Treatment|January 17, 2012
Phase II trial of temsirolimus in patients with metastatic breast cancerGini F Fleming, Cynthia X Ma, Dezheng Huo, et al.
Pageof 16